Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of Novel Psychoactive Substances
View/ Open
Author
Deligianni, Elena
Daniel, Omari-Jordan
Corkery, John
Schifano, Fabrizio
Lione, Lisa
Attention
2299/21684
Abstract
Aims: The risk of potential harms prompted the UK government to introduce the Psychoactive Substances Act in 2016. The aim of the present study was to evaluate the impact and effectiveness of this new legislation on patterns of novel psychoactive substance (NPS) awareness, use, experiences and risk awareness in a self-selected sample of UK consumers to inform education and policy. Methods: The Bristol Online Survey was advertised on the Bluelight drug forum and social media Facebook pages and University email between 7 January and 7 February 2015 (168 responses) and 9 March to 18 September 2017 (726 responses). UK country of residence responses were extracted for analysis (SPSS). Results: In a predominantly university-educated, young (< 25 years) self-selecting sample, 1 year after introduction of the legislation, NPS use (in males, under 18s, those educated to school/college level, P <.001) has increased, whilst health risk awareness has not changed and remains poor. Users are switching to sourcing NPSs via street dealers (49%) and the darknet (31%) and showing an increase in preference for the herbal NPS Salvia divinorum (P <.05). The main reasons for NPS use remain the influence of friends (69%) in a social setting and to get high (76%) usually in combination with alcohol, cannabis or ecstasy. Conclusion: Regulation alone, so far, has not impacted on health risk awareness, NPS drug demand and culture in our UK survey sample. Alongside regulation, NPS health promotion education (particularly in schools, colleges) is needed that addresses resilience and both the risks and beneficial effects of NPS.
Publication date
2020-03-01Published in
British Journal of Clinical PharmacologyPublished version
https://doi.org/10.1111/bcp.14123Other links
http://hdl.handle.net/2299/21684Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
Kirton, Stewart; Botha, Michelle (2022-11-01)New psychoactive substances (NPS) are a group of compounds that mimic the effects of illicit substances. A range of NPS have been shown to interact with the three main classes of monoamine transporters (DAT, NET, and SERT) ... -
Novel Psychoactive Substance (NPS) awareness, use and health perception following The UK Psychoactive Substances Act 2016
Deligianni, Elena; Daniel, Omari-Jordan; Corkery, John; Schifano, Fabrizio; Lione, Lisa (2017-10-23)Introduction: The risk of potential harms prompted the UK government to introduce The Psychoactive Substances Act (PSA) in 2016 banning the production, supply, importation and exportation of NPS 1. Here we investigate UK ... -
Mapping novel psychoactive substances policy in the EU : The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden
Neicun, Jessica; Steenhuizen, Marthe; van Kessel, Robin; Yang, Justin C; Negri, Attilio; Czabanowska, Katarzyna; Corazza, Ornella; Roman-Urrestarazu, Andres (2019-06-26)INTRODUCTION: The rapid rise in trade and use of NPS and the lack of information concerning their potential toxicity pose serious challenges to public health authorities across the world. Policy measures towards NPS taken ...